Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404-REGOLD

Affiliation auteurs!!!! Error affiliation !!!!
TitrePhase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404-REGOLD
Type de publicationJournal Article
Year of Publication2018
AuteursAparicio T., A. Jouve D, Khemissa F., Monterymard C., Artru P., Cany L., Romano O., Valenza B., Le Foll C., Delbaldo C., Falandry C., Duluc M., Rinaldi Y., Legoux J.L, Ben Abdelghani M., Assenat E., Dhooge M., Smith D., G. Guetz D, Lepage C.
JournalANNALS OF ONCOLOGY
Volume29
Pagination156
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534